Acorda Therapeutics, Inc. (NASDAQ:ACOR)
CAPS Rating:
A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.
RSS Headlines
Fool UK
Recs
tspy rec